| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | TAG-72 |
| Clinical data | |
| Other names | MAb B72.3-GYK-DTPA |
| ATC code |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
| UNII |
|
 N Y (what is this?) (verify) | |
Indium (111In) satumomab pendetide (trade name OncoScint CR103) is a mouse monoclonal antibody which is used for cancer diagnosis.[1] The antibody, satumomab, is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111.
References
- ^ García-Fernández R, Luna-Pérez P, Hernández-Hernández DM, Iwasaki-Otake L, Pichardo-Romero P, Rodríguez-Ramirez S (2002). "[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence]". Gaceta Médica de México. 138 (2): 139–44. PMID 12001423.
External links
- Drugs.com Satumomab pendetide
 | This nuclear medicine article is a stub. You can help Wikipedia by adding missing information. |
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by adding missing information. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by adding missing information. |
